Press release
Oral Biologics And Biosimilars Market 2020 Global Analysis, Trends, Forecast up to 2030 | Merck & Co, GlaxoSmithKline, Novo Nordisk, ALK-Abello A/S, Aimmune Therapeutics, Inc.
Oral Biologics And Biosimilars Market
The global oral biologics and biosimilars market reached a value of nearly $3,076.1 million in 2019, having grown at a compound annual growth rate (CAGR) of 6.5% since 2015, and is expected to grow at a CAGR of 17.1% to nearly $5,787.9 million by 2023. Also, the market is expected to growth to $8,687.7 million in 2025 at a CAGR of 22.5% and to $23,585.5 million in 2030 at a CAGR of 22.1%.
The key drivers of the oral biologics & biosimilars market include:
Technological Advances:
Technology is expected to be a continued driver of market growth during this period. An area of particular development is likely to be physiology simulation modeling. Markets such as this one will benefit from the greater efficiencies offered by developments in this area. For example, Eli Lilly and Pfizer have adopted Amazon’s Elastic Compute Cloud (EC2) platform to conduct simulation models in early drug discovery that have been operational within hours, whereas traditional models would have taken weeks to conduct simulations. The Open Innovation Drug Discovery program is another initiative by Lilly to enhance the research and development of biologics.
Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilars-market
Oral Biologics & Biosimilars Market Segmentation:
The oral biologics & biosimilars market is segmented by therapeutic mechanism, disease, molecule type, distribution channel and by geography.?
By Therapeutic Mechanism - The oral biologics & biosimilars market can be segmented by therapeutic mechanism
a. Tumor Necrosis Factor-Alpha Inhibitors
b. Lymphocyte Modulators
c. Interleukin Inhibitors
d. GPCR (insulin, growth hormone, parathyroid hormone) Modulators
e. Immunostimulants
f. Others
The others (Interferons, Opioid receptors, Calcitonin receptor) was the largest segment of the oral biologics and biosimilars market by therapeutic mechanism, accounting for $676.1 million of the total market in 2019.
By Disease – The oral biologics & biosimilars market can be segmented by disease
a. Diabetes
b. Arthritis & Chron`s Disease
c. Cancer
d. Infectious Diseases
e. Other Autoimmune Diseases
f. Others Diseases
The infectious diseases was the largest segment of the oral biologics and biosimilars market by disease, accounting for $2,305.6 million or 74.9% of the total market in 2019 and this market is expected to grow at a CAGR of 7.1% during 2019-2023. The diabetes market is expected to be the fastest-growing segment going forward at a CAGR of 82.6%.
Request For A Sample Copy Of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3361&type=smp
By Geography - The oral biologics & biosimilars market is segmented into
1.North America
2.Western Europe
3.Asia Pacific
4.Eastern Europe
5.South America
6.Middle East
7.Africa
Some of the major key players involved in oral biologics & biosimilars market are
• Merck & Co
• GlaxoSmithKline
• Novo Nordisk
• ALK-Abello A/S
• Aimmune Therapeutics, Inc.
Place a DIRECT PURCHASE ORDER of entire 300+ pages report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3361
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/
About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oral Biologics And Biosimilars Market 2020 Global Analysis, Trends, Forecast up to 2030 | Merck & Co, GlaxoSmithKline, Novo Nordisk, ALK-Abello A/S, Aimmune Therapeutics, Inc. here
News-ID: 2128907 • Views: …
More Releases from The Business research company
Analysis of Key Market Segments Influencing the Extraterrestrial Legal Systems M …
Exploring the Future of Extraterrestrial Legal Systems
As humanity advances its presence beyond Earth, the need for specialized legal frameworks governing activities in outer space is becoming increasingly critical. The extraterrestrial legal systems market is set to expand rapidly, driven by the complexities of managing property rights, regulatory compliance, and dispute resolution in off-world environments. Let's delve into the anticipated market value, key players, significant trends, and the main segments shaping…
Emerging Growth Trends Driving Expansion in the Explosion Proof Cabins Market
The explosion proof cabins market is set to experience significant growth over the coming years, driven by increasing industrial safety demands and technological advancements. This market's evolution is shaped by emerging materials, innovative designs, and expanding applications, which all contribute to the rising adoption of explosion-resistant cabins in hazardous environments.
Forecast of the Explosion Proof Cabins Market Size by 2030
The explosion proof cabins market is projected to reach a value of…
Market Structure, Emerging Trends, and Key Player Analysis of the Electronic Pay …
The electronic payload fairing separation system market is poised for impressive expansion as innovations and technological advancements continue to reshape space launch operations. This report delves into the anticipated market size, key players, emerging trends, and segment classifications, offering a comprehensive overview of this specialized aerospace sector.
Projected Market Size and Growth Trajectory for Electronic Payload Fairing Separation Systems
The market for electronic payload fairing separation systems is forecasted to achieve substantial…
Leading Companies Fueling Growth and Innovation in the Dual Mode Microwave Seeke …
The dual mode microwave seeker market is positioned for significant expansion over the coming years, driven by a range of technological advancements and increasing defense requirements. This segment plays a crucial role in modern warfare and missile guidance, with innovation and integration shaping its future trajectory. Let's explore the current market size, key drivers, major players, and segmentation of this specialized industry.
Projected Market Growth for the Dual Mode Microwave Seeker…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
